Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This clinical study will test the short-term efficacy of interleukin-2 gargle combined with
systemic use of glucocorticoids in the treatment of oral mucosal lesions in mucosal-dominant
pemphigus vulgaris and moderate mucocutaneous pemphigus vulgaris.
Phase:
Phase 2
Details
Lead Sponsor:
Second Xiangya Hospital of Central South University